BioNTech SE (LTS:0A3M)
$ 107.65 -1.25 (-1.15%) Market Cap: 25.81 Bil Enterprise Value: 7.53 Bil PE Ratio: 0 PB Ratio: 1.23 GF Score: 63/100

BioNTech SE Capital Markets Day Transcript

Nov 07, 2023 / 02:00PM GMT
Release Date Price: $98.7 (-1.13%)
Ryan Richardson
BioNTech SE - Chief Strategy Officer, MD & Member of Management Board

Good morning. Good afternoon for those of you on the livestream. It's my pleasure to be with you here today and to introduce BioNtech's Second Annual Innovation Series event. My name is Ryan Richardson, I'm the Chief Strategy Officer of BioNTech. It's a particular pleasure to be here in Boston.

Just a couple of years ago, BioNTech set its U.S. headquarters here at Boston really with humble beginnings, and we've -- pre-pandemic, and we've grown our presence here now to almost 500 people. And I think it's fair to say we're really already embedded in the dynamic ecosystem here in the city, which is fantastic.

We are going to be making forward-looking statements today, which you shouldn't put undue reliance on because future events could differ from, of course, our anticipated events or plans. For a full description of the risks, of course, please refer to our 20-F annual report and other documents filed with the SEC.

So we have a packed agenda today over the next couple of hours. It's going

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot